NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Income Statement
Europe - Frankfurt Stock Exchange - FRA:NZM2 - DK0060336014 - Common Stock
53.2 EUR
-0.36 (-0.67%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 5.16B | 3.83B | 2.40B | 2.35B | 2.01B | |||
| Minority Interest Expense | 0.00 | 0.00 | -2.01M | -1.34M | 134.10K | |||
| Cost Of Goods | 2.44B | 2.02B | 1.10B | 1.07B | 846.61M | |||
| Gross Profit | 2.73B | 1.81B | 1.30B | 1.28B | 1.16B | |||
| Operating Expenses | 1.59B | 1.15B | 704.22M | 685.88M | 631.77M | |||
| Research and Development | 554.20M | 333.40M | 232.38M | 221.66M | 222.88M | |||
| Selling, General, and Administrative Expenses | 1.07B | 659.50M | 416.67M | 400.19M | 345.99M | |||
| Operating Income | 1.13B | 659.00M | 597.88M | 596.81M | 526.63M | |||
| Interest Income/Expense | -92.30M | -72.10M | -20.36M | -50.63M | -10.06M | |||
| Other Income/Expense | N/A | -11.80M | 11.12M | 14.20M | -1.07M | |||
| Non Recurring Items | -120.10M | -158.00M | -65.09M | 49.82M | 10.73M | |||
| Income Before Taxes | 917.80M | 417.10M | 523.55M | 610.20M | 526.23M | |||
| Income Tax | 215.10M | 111.30M | 116.52M | 116.52M | 104.47M | |||
| Net Income | 702.70M | 305.80M | 405.02M | 492.34M | 421.90M | |||
| EBITDA | N/A | 1.26B | 783.92M | 795.70M | 716.53M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.51 | 0.67 | 1.46 | 1.77 | 1.51 | |||
| Non GAAP EPS | N/A | N/A | 3.90 | 13.20 | 11.23 | |||
| Statistics | ||||||||
| Gross Profit Margin | 52.79% | 47.20% | 54.32% | 54.56% | 57.78% | |||
| Profit Margin | 13.61% | 7.98% | 16.89% | 20.94% | 21.04% | |||
| Operating Profit Margin | 21.89% | 17.19% | 24.94% | 25.39% | 26.27% | |||
All data in EUR